About
Brian has over 25 years of experience in legal and business roles in the life sciences sector. His diverse background makes him a valuable partner for his clients. Brian has extensive experience assisting clients with the leasing, build out, and operation of R&D laboratories. He has drafted and negotiated leases in major life sciences markets across the United States, including the Greater Boston/Cambridge areas, New Jersey, Philadelphia, Raleigh, San Diego, San Francisco and Seattle. Brian also assists clients within the biopharmaceutical industry on a broad range of commercial and corporate matters but has a unique expertise assisting clients with CMC-related matters and supply chain and distribution arrangements for both clinical and commercial pharmaceutical products and devices.
-
Brian also currently serves as the CEO of TheracosBio, LLC, a Massachusetts-based commercial stage pharmaceutical company that provides cost-effective solutions to patients with Type 2 diabetes. Prior to that, Brian co-founded IncreVet, Inc., which developed the first FDA-approved oral treatment for feline diabetes before being acquired in early 2022. Brian has also held legal and business development roles within an S&P 500 diagnostics company.
Practices
Commercial Transactions
Emerging Companies
FDA
FinTech and Blockchain
Mergers and Acquisitions
Private Equity and Venture Capital
Real Estate
Technology
Admissions
Massachusetts
New Hampshire
Education
The George Washington University Law School
London School of Economics
Boston College
Law Firm Experience
Faber, Daeufer & Itrato PC
Foley Hoag LLP
Corporate Experience
TheracosBio – Chief Executive Officer
IncreVet, Inc. - Co-Founder and Chief Operating Officer
IDEXX Laboratories, Inc. - Senior Manager for Business Development & Associate General Counsel